Published date: 11 August 2022

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 11 February 2022, 1pm

Contract summary

Industry

  • Influenza vaccines - 33651660

Location of contract

United Kingdom

Value of contract

£0

Procurement reference

CF-0983800D0O000000rwimUAA

Published date

11 August 2022

Closing date

11 February 2022

Closing time

1pm

Contract start date

1 August 2022

Contract end date

31 July 2024

Contract type

Supply contract

Procedure type

Negotiated procedure without prior publication (above threshold)

The opportunity was not advertised, because for example only one supplier is capable of delivering the requirement, or due to extreme urgency brought about by unforeseen events.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

Description

The provision of a live attenuated influenza vaccine. Deliveries will be required over the initial term of 2 years and the contract has the option to be extended for up to an additional 24 months.

Value - The value has been withheld so as not to prejudice the legitimate commercial interest of the supplier.

More information

Attachments

Award information

Awarded date

15 July 2022

Contract start date

1 August 2022

Contract end date

31 July 2024

Total value of contract

£1

This contract was awarded to 1 supplier.

AstraZeneca UK Ltd

Address

1 Francis Crick Avenue
Cambridge Biomedical Campus CB2 0AA

Reference

None

Supplier is SME?

No

About the buyer

Contact name

Chantal Jockel

Address

Premier House, 60 Caversham Road
Reading
RG1 7EB
GB

Email

chantal.jockel@dhsc.gov.uk